Perceptive Advisors LLC Kronos Bio, Inc. Transaction History

Perceptive Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.44 - $3.44 $580,904 - $1.39 Million	-403,406 Reduced 18.71%	1,752,745 $2.84 Million
Q3 2022 Nov 14, 2022	SELL	$3.35 - $5.55 $887,719 - $1.47 Million	-264,991 Reduced 10.94%	2,156,151 $7.22 Million
Q3 2021 Nov 15, 2021	SELL	$18.17 - $24.7 $1.94 Million - $2.64 Million	-106,910 Reduced 4.23%	2,421,142 $50.7 Million
Q2 2021 Aug 16, 2021	SELL	$20.08 - $29.02 $5.06 Million - $7.31 Million	-252,045 Reduced 9.07%	2,528,052 $60.5 Million
Q4 2020 Feb 16, 2021	BUY	$26.68 - $38.23 $74.2 Million - $106 Million	2,780,097 New	2,780,097 $83 Million

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $53.9M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.